Kunwei Shen
Impact in
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
- Cancer Research 141
- Breast Cancer Treatment Studies 111
- Cancer Genomics and Diagnostics 15
- Oncology 156
- HER2/EGFR in Cancer Research 78
- Cancer Treatment and Pharmacology 30
- Cancer Risks and Factors 17
- Cancer Immunotherapy and Biomarkers 16
- Co-authors
- Xiaosong ChenYan MaoJiayi WuOu HuangDavid GarfieldXiaochun FeiEvan T. KellerJianhua Wang
- Journals
- Frontiers in Oncology (19 papers)Breast Cancer Research and Treatment (13 papers)Cancer Research (8 papers)BMC Cancer (7 papers)PLoS ONE (7 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Kunwei Shen
213 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Cancer Research 2.2k
- Oncology 2.7k
- Pathology and Forensic Medicine 797
- Radiology, Nuclear Medicine and Imaging 792
- Pulmonary and Respiratory Medicine 914
Countries citing papers authored by Kunwei Shen
This map shows the geographic impact of Kunwei Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kunwei Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kunwei Shen more than expected).
Fields of papers citing papers by Kunwei Shen
This network shows the impact of papers produced by Kunwei Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kunwei Shen. The network helps show where Kunwei Shen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kunwei Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 10 | |
| 3 | 2023 | 29 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 6 | |
| 7 | 2022 | 0 | |
| 8 | 2021 | 12 | |
| 9 | 2021 | 18 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 2 | |
| 12 | 2020 | 166 | |
| 13 | 2020 | 7 | |
| 14 | 2016 | 105 | |
| 15 | [Effect of body mass index on disease-free and overall survival in Chinese women with breast cancer]. | 2015 | 2 |
| 16 | [Risk factors of non-sentinel lymph node metastasis and performance of MSKCC nomogramin breast cancer patients with metastatic sentinel lymph node]. | 2015 | 6 |
| 17 | 2015 | 26 | |
| 18 | 2013 | 36 | |
| 19 | 2013 | 2 | |
| 20 | Significantly Higher Pathologic Complete Remission Rate after Neoadjuvant Therapy with Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy | 2006 | 5 |
About Kunwei Shen
Kunwei Shen is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 231 papers that have together received 5.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (111 papers), HER2/EGFR in Cancer Research (78 papers), Breast Lesions and Carcinomas (48 papers), Advanced Breast Cancer Therapies (38 papers), Cancer Treatment and Pharmacology (30 papers), Cancer Risks and Factors (17 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Cancer Genomics and Diagnostics (15 papers). The work is most often cited by research in Cancer Research (2.2k citations), Oncology (2.7k citations), Pathology and Forensic Medicine (797 citations), Radiology, Nuclear Medicine and Imaging (792 citations) and Pulmonary and Respiratory Medicine (914 citations). Kunwei Shen has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Xiaosong Chen, Yan Mao, Jiayi Wu, Ou Huang, David Garfield, Xiaochun Fei, Evan T. Keller, Jianhua Wang, Weiguo Chen and Shuning Ding. Their work appears in journals such as Frontiers in Oncology, Breast Cancer Research and Treatment, Cancer Research, BMC Cancer and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.